Vetter also performs successfully at the CMO Leadership Awards in 2021

- Vetter scores with excellent ratings in key categories
- Results reflect positive customer experiences
- Award emphasizes the high customer focus of the pharmaceutical service provider

Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), was also recognized in 2021 at the CMO Leadership Awards. The pharmaceutical service provider excelled in five main categories – Quality, Expertise, Compatibility, Portfolio, and Service. The magazine Life Science Leader, one of the industry’s leading trade journals, awarded the prize for the tenth time this year. In previous years, Vetter had already won in multiple categories.

“It is a great honor for Vetter to once again be among the winners of the CMO Leadership Awards. This recognition is especially meaningful to us given the challenging and turbulent times we are experiencing due to the global Covid-19 pandemic,” said Vetter CEO Peter Sölkner. Carsten Press, Senior Vice President of Key Account Management/Supply Chain Management/Marketing at Vetter, adds: “The recognition in five main categories shows that we are seen by our customers as a competent and valued partner who makes a significant contribution to supplying their patients with vital medicines.”

Often, winners of awards are determined through an application process. However, the CMO Leadership Awards are exclusively decided based on extensive customer evaluations. The decisive factor is the experience of pharmaceutical and biotech companies in their specific collaboration with their service providers. The award affirms that the winners demonstrate a particularly high level of performance in this regard.

“The past months have shown how important CDMOs are as strong partners for biopharma companies,” explains Louis Garguilo, Editor-in-Chief of the trade magazine Outsourced Pharma. “Thanks to their flexibility, medicines can still be reliably developed and manufactured even during a pandemic.”